{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:52:41Z","timestamp":1762980761517,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA199167","R01HL118740","R21CA226960"],"award-info":[{"award-number":["R01CA199167","R01HL118740","R21CA226960"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ccl.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T08:50:56Z","timestamp":1567241456000},"page":"429-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["MRI of Cardiotoxicity"],"prefix":"10.1016","volume":"37","author":[{"given":"Jennifer Hawthorne","family":"Jordan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William Gregory","family":"Hundley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ccl.2019.07.007_bib1","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2011.40.3584","article-title":"Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging","volume":"30","author":"Armstrong","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.ccl.2019.07.007_bib2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.ccl.2019.07.007_bib3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.007_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurjhf\/hfq213","article-title":"Cardiovascular side effects of cancer therapies: a position statement from the heart failure association of the European Society of Cardiology","volume":"13","author":"Eschenhagen","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.ccl.2019.07.007_bib5","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jcmg.2018.06.004","article-title":"Cardiovascular magnetic resonance in the oncology patient","volume":"11","author":"Jordan","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ccl.2019.07.007_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MNM.0b013e328025ae04","article-title":"Trastuzumab-induced cardiac dysfunction","volume":"28","author":"Panjrath","year":"2007","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.007_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jchf.2012.09.001","article-title":"The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients","volume":"1","author":"Hall","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.ccl.2019.07.007_bib8","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.amjcard.2017.02.008","article-title":"Frequency of left ventricular end-diastolic volume-mediated declines in ejection fraction in patients receiving potentially cardiotoxic cancer treatment","volume":"119","author":"Melendez","year":"2017","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ccl.2019.07.007_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","volume":"6","author":"Drafts","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ccl.2019.07.007_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2018.10.023","article-title":"CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mapping","volume":"275","author":"Haslbauer","year":"2019","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2019.07.007_bib11","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/CIRCIMAGING.113.000899","article-title":"Cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy: a systematic review","volume":"6","author":"Thavendiranathan","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.007_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12968-017-0373-3","article-title":"Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy","volume":"19","author":"Jolly","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"3","key":"10.1016\/j.ccl.2019.07.007_bib13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5603\/CJ.a2016.0023","article-title":"Cardiac magnetic resonance imaging-based myocardial strain study for evaluation of cardiotoxicity in breast cancer patients treated with trastuzumab: a pilot study to evaluate the feasibility of the method","volume":"23","author":"Nakano","year":"2016","journal-title":"Cardiol J"},{"key":"10.1016\/j.ccl.2019.07.007_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijcard.2018.03.041","article-title":"Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy","volume":"261","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ccl.2019.07.007_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1532-429X-13-83","article-title":"Comprehensive cardiovascular magnetic resonance of myocardial mechanics in mice using three-dimensional cine DENSE","volume":"13","author":"Zhong","year":"2011","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"25","key":"10.1016\/j.ccl.2019.07.007_bib16","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/CIRCULATIONAHA.117.027930","article-title":"Early myocardial strain changes during potentially cardiotoxic chemotherapy may occur as a result of reductions in left ventricular end-diastolic volume: the need to interpret left ventricular strain with volumes","volume":"135","author":"Jordan","year":"2017","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ccl.2019.07.007_bib17","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"Fallah-Rad","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ccl.2019.07.007_bib18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jcmg.2018.03.019","article-title":"Rationale and design of the strain surveillance of chemotherapy for improving cardiovascular outcomes: the SUCCOUR trial","volume":"11","author":"Negishi","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"16","key":"10.1016\/j.ccl.2019.07.007_bib19","first-page":"4592","article-title":"Doxorubicin treatment in\u00a0vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio","volume":"62","author":"Childs","year":"2002","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ccl.2019.07.007_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00109-008-0434-z","article-title":"ARC is a critical cardiomyocyte survival switch in doxorubicin cardiotoxicity","volume":"87","author":"An","year":"2009","journal-title":"J\u00a0Mol Med (Berl)"},{"issue":"3","key":"10.1016\/j.ccl.2019.07.007_bib21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0022-2836(92)90863-F","article-title":"Mode of action of topoisomerase II-targeting agents at a specific DNA sequence: uncoupling the DNA binding, cleavage and religation events","volume":"228","author":"Sorensen","year":"1992","journal-title":"J\u00a0Mol Biol"},{"issue":"21","key":"10.1016\/j.ccl.2019.07.007_bib22","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.jacc.2011.01.024","article-title":"Dietary nitrate supplementation protects against doxorubicin-induced cardiomyopathy by improving mitochondrial function","volume":"57","author":"Zhu","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2019.07.007_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/mol.63.2.368","article-title":"Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis","volume":"63","author":"Kim","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.007_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1021\/tx9003424","article-title":"Anthracycline degradation in cardiomyocytes: a journey to oxidative survival","volume":"23","author":"Menna","year":"2010","journal-title":"Chem Res Toxicol"},{"issue":"7","key":"10.1016\/j.ccl.2019.07.007_bib25","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.amjcard.2006.10.063","article-title":"Acute cardiac functional and morphological changes after anthracycline infusions in children","volume":"99","author":"Ganame","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2019.07.007_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1532-429X-15-48","article-title":"Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling","volume":"15","author":"Tham","year":"2013","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"11","key":"10.1016\/j.ccl.2019.07.007_bib27","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.amjcard.2012.07.040","article-title":"Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines","volume":"110","author":"Neilan","year":"2012","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2019.07.007_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1203\/00006450-199603000-00020","article-title":"Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors","volume":"39","author":"De Wolf","year":"1996","journal-title":"Pediatr Res"},{"issue":"10","key":"10.1016\/j.ccl.2019.07.007_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/clc.4960241006","article-title":"Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood","volume":"24","author":"Iarussi","year":"2001","journal-title":"Clin Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2019.07.007_bib30","doi-asserted-by":"crossref","first-page":"e004560","DOI":"10.1161\/CIRCHEARTFAILURE.117.004560","article-title":"Left ventricular mass change after anthracycline chemotherapy","volume":"11","author":"Jordan","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1016\/j.ccl.2019.07.007_bib31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcmg.2018.05.012","article-title":"Anthracycline therapy is associated with cardiomyocyte atrophy and preclinical manifestations of heart disease","volume":"11","author":"de Souza","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ccl.2019.07.007_bib32","doi-asserted-by":"crossref","first-page":"e005234","DOI":"10.1161\/CIRCHEARTFAILURE.118.005234","article-title":"Doxorubicin exposure causes subacute cardiac atrophy dependent on the striated muscle-specific ubiquitin ligase MuRF1","volume":"12","author":"Willis","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.007_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"Messroghli","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"24","key":"10.1016\/j.ccl.2019.07.007_bib34","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2019.07.007_bib35","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/0002-8703(87)90660-0","article-title":"Adriamycin cardiotoxicity and proton nuclear-magnetic-resonance relaxation properties","volume":"113","author":"Thompson","year":"1987","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.ccl.2019.07.007_bib36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1139\/y94-022","article-title":"Early incidence of adriamycin treatment on cardiac parameters in the rat","volume":"72","author":"Cottin","year":"1994","journal-title":"Can J Physiol Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.ccl.2019.07.007_bib37","doi-asserted-by":"crossref","first-page":"P273","DOI":"10.1186\/1532-429X-16-S1-P273","article-title":"Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab","volume":"16","author":"Thavendiranathan","year":"2014","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"5","key":"10.1016\/j.ccl.2019.07.007_bib38","doi-asserted-by":"crossref","first-page":"e008777","DOI":"10.1161\/CIRCIMAGING.118.008777","article-title":"Early detection of anthracycline-induced cardiotoxicity in breast cancer survivors with T2 cardiac magnetic resonance","volume":"12","author":"Lustberg","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ccl.2019.07.007_bib39","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mhj.2001.115436","article-title":"Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging - a pilot study","volume":"141","author":"Wassmuth","year":"2001","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ccl.2019.07.007_bib40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCIMAGING.109.918540","article-title":"Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model","volume":"3","author":"Lightfoot","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ccl.2019.07.007_bib41","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCIMAGING.114.002217","volume":"7","author":"Jordan","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.ccl.2019.07.007_bib42","first-page":"1283","article-title":"Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy","volume":"21","author":"Lunning","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.007_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1532-429X-10-5","article-title":"Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy","volume":"10","author":"Fallah-Rad","year":"2008","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.007_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1743-7563.2011.01462.x","article-title":"Pilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancer","volume":"8","author":"Lawley","year":"2012","journal-title":"Asia Pac J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ccl.2019.07.007_bib45","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.ccl.2019.07.007_bib46","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.ccl.2019.07.007_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"issue":"10124","key":"10.1016\/j.ccl.2019.07.007_bib48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(18)30533-6","article-title":"Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis","volume":"391","author":"Moslehi","year":"2018","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ccl.2019.07.007_bib49","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9 Supplement 1","key":"10.1016\/j.ccl.2019.07.007_bib50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0735-1097(19)31283-5","article-title":"Late gadolinium enhancement in patients with myocarditis from immune checkpoint inhibitors","volume":"73","author":"Zhang","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.007_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1532-429X-12-S1-P100","article-title":"Myocardial extracellular volume imaging allows quantitative assessment of atypical late gadolinium enhancement","volume":"12","author":"Ugander","year":"2010","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.007_bib52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1532-429X-13-S1-P148","article-title":"Myocardial extracellular volume imaging by CMR quantitatively characterizes myocardial infarction and subclinical myocardial fibrosis","volume":"13","author":"Ugander","year":"2011","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"2","key":"10.1016\/j.ccl.2019.07.007_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.109.930636","article-title":"Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans","volume":"122","author":"Flett","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2019.07.007_bib54","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1148\/radiol.13130130","article-title":"Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings","volume":"269","author":"Bandula","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ccl.2019.07.007_bib55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1532-429X-14-88","article-title":"Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR","volume":"14","author":"Fontana","year":"2012","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"6","key":"10.1016\/j.ccl.2019.07.007_bib56","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/CIRCIMAGING.108.842096","article-title":"Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease","volume":"3","author":"Broberg","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.ccl.2019.07.007_bib57","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amjcard.2012.11.022","article-title":"Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy","volume":"111","author":"Neilan","year":"2013","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ccl.2019.07.007_bib58","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004325","article-title":"Anthracycline-associated T1 mapping characteristics are elevated independent of the presence of cardiovascular comorbidities in cancer survivors","volume":"9","author":"Jordan","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ccl.2019.07.007_bib59","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jcmg.2016.06.006","article-title":"Progressive 3-month increase in LV myocardial ECV after anthracycline-based chemotherapy","volume":"10","author":"Melendez","year":"2017","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865119300566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865119300566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:51:03Z","timestamp":1760007063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865119300566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0733865119300566"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2019.07.007","relation":{},"ISSN":["0733-8651"],"issn-type":[{"type":"print","value":"0733-8651"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI of Cardiotoxicity","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}